An invitation from Novartis
Frontline Hodgkin Lymphoma Expert Case discussion
Invitation from Takeda –
Prophylaxis of IFI and CMV in AML/HSCT Patients
MSH Meeting 2020: YOU COULD BE THE LUCKY ONE!!!
WHO? ME? YES YOU !!!!!
Announcement: MSH Meeting 2020 10th – 12th September 2020 : Virtual Screening
We are happy to announce there will be a concurrent physical and virtual meeting for the forth-coming MSH Meeting 2020 . The whole event will be broad-cast virtually from Kuala Lumpur. For those who have registered for our physical meeting, and now wished to attend the meeting online, may do so but there will be […]
Amendment: ICBMT 2020
Attached the amended copy
Announcement: MSH 26th Annual General Meeting – 10th September 2020
Happy to inform our 26th Annual General Meeting has been re-scheduled to September 10th, 2020. Time and venue to be confirmed at a later date.
Updated: ICBMT 2020: 10th – 12th September 2020
Updated info from Organizers:
A Study of Paroxysmal Nocturnal Haemoglobinuria (PNH)
Currently there is a study of Paroxysmal Nocturnal Haemoglobinuria (PNH) recruiting for patients. Please find below the details of the study:
Announcement: EXIT VIVA EXAM Part 2 – 6TH OCT 2020
Criteria for Exit Viva Exam Part 2: Candidate must: *Have completed their 3 years’ Haematology training, *Require supervisor’s approval and report *Complete dissertation successfully or have a publication ( case report not included but case series are acceptable) *Submit their application form, by 26th August 2020 *Submit Logbook and thesis to the exam committee by […]